Resources
About Us
Home Report
Store
Pharmaceutical Packaging Market
Pharmaceutical Packaging Market by Material (Polymer [PE, PP, PET], Glass, Paper, Metal) Type (Bottles, Blister, PFS, Caps, Vials, Ampoules, Sachet, Inhaler, Secondary, Tertiary) Dosage Form (Oral, Parenteral, Topical), End User - Global Forecast to 2031
Report ID:MRHC - 104612 Pages: 348 Apr-2024 Formats*: PDF Category: Healthcare Delivery: 2 to 4 HoursThe Pharmaceutical Packaging Market was valued at $98.89 billion in 2023. This market is expected to reach $176.54 billion by 2031, from an estimated $105.73 billion in 2024, at a CAGR of 7.6% during the forecast period 2024-2031.
Pharmaceutical Packaging Market Size & Forecast
Pharmaceutical packaging, also known as drug packaging or medical packaging, involves the use of appropriate materials or containers for storing and distributing pharmaceutical preparations. In addition to storing and protecting drugs, pharmaceutical packaging is also used for identification purposes, marketing, and promoting different brands. The types of pharmaceutical packaging include primary, secondary, and tertiary. Primary drug packaging surrounds the pharmaceutical product, while secondary and tertiary packaging provide additional external protection.
Growth in the Pharmaceutical Sector is Driving the Market
The pharmaceutical industry has witnessed rapid growth over the years. According to the India Brand Equity Foundation (India), the pharmaceutical industry in India is expected to reach USD 130 billion by 2030 from USD 42 billion in 2021. The rising need for novel therapies, increasing pharmaceutical R&D expenditures, the rising prevalence of chronic diseases, and increasing funding for drug discovery are some of the factors driving the growth of the pharmaceutical industry.
In June 2023, the Commonwealth Government’s Medical Research Future Fund (MRFF) (Australia) invested USD 9.75 million in establishing MedChem Australia, a new national medicinal chemistry initiative, to accelerate the identification of early-stage drug candidates. Similarly, in July 2022, the Council of Scientific and Industrial Research (CSIR) (India) invested USD 6.73 million in R&D activities for drug discovery and development. Increasing funding for drug discovery & development is expected to increase the availability of new medicines, boosting the demand for packaging.
Pharmaceutical preparations are considered important in enhancing patients’ quality of life. Their consumption is increasing due to the growing need to treat age-related & chronic diseases and changes in clinical practices.
Further, according to the European Federation of Pharmaceutical Industries and Associations (Belgium), the pharmaceutical R&D expenditure growth rate in China increased to 15.6% between 2018-2022 from 13.6% in 2013-2017. Also, in Europe, the pharmaceutical R&D expenditure growth rate increased to 4.6% in 2018-2022 from 3.2% in 2013-2017.
Thus, increasing pharmaceutical R&D expenditure, growth in the pharmaceutical industry, and rising funding for drug discovery & development are driving the demand for drug packaging.
Click here to: Get Free Sample Pages of this Report
Rising Adoption of Personalized Medicines & a Practice of Self-medication Generating Growth Opportunities for Market Players
Personalized/precision medicine uses an individual’s genomic information to offer targeted treatments. As precision medicine is based on individuals’ genetic makeup, it can overcome the limitations of traditional medicines and provide effective treatment. The growing interest in personalized medication, particularly in the fields of gene therapy, cancer, and cell therapy, has increased the need for custom drug delivery systems and pharmaceutical primary packaging. The smaller batch sizes and high costs of personalized medicines are increasing the need for intelligent packaging to ensure supply chain visibility and prevent counterfeiting.
Personalized medicine packaging also requires custom labeling for patient education. The label should include the patient’s name, formulation, and dosage requirement to avoid the mixing of medicines and reduce the chances of potential health hazards. Thus, the rising adoption of personalized medicines is increasing the need for customized packaging, driving the pharmaceutical packaging market.
Patients who prefer to self-medicate require reliable and simple drug delivery solutions that can support effective treatment outcomes. Drug delivery systems and pharmaceutical containment solutions must be created to prevent medication errors and make drug delivery easier. Thus, the trend of self-medication has increased the demand for drug delivery solutions like nasal sprays and autoinjectors. Additionally, healthcare staff shortages, growth in the aging population, and financial pressures are further supporting the self-medication trend, boosting the demand for pharmaceutical packaging solutions.
Key Findings in the Global Pharmaceutical Packaging Market Study:
Based on Materials, in 2024, the Polymer Segment is Expected to Account for the Largest Share of the Market
Based on material, the pharmaceutical packaging market is segmented into polymer, glass, paper & paperboard, metal, and other materials. In 2024, the polymer segment is expected to account for the largest share of the pharmaceutical packaging market. The segment’s large share is attributed to the wide availability of polymers, the cost-effectiveness of polymers compared to other packaging materials, such as glass and metal, and the effectiveness of polymers in protecting pharmaceutical preparations against external damage and contamination. The use of eco-friendly/recycled/biodegradable polymers in pharmaceutical packaging is a recent trend in pharmaceutical packaging. For instance, In August 2022, Röchling Medical (Germany), a pharmaceutical packaging company, collaborated with LyondellBasell Industries N.V. (Netherlands). The companies created eye drop containers made by Röchling Medical using CirculenRenew polymers. LyondellBasell and Röchling used LDPE for the packaging.
Based on Packaging Type, the Primary Packaging Segment is Projected to Register the Highest CAGR During the Forecast Period
Based on packaging type, the pharmaceutical packaging market is segmented into primary packaging, secondary packaging, and tertiary packaging. The primary packaging segment is projected to register the highest CAGR during the forecast period. The highest CAGR of the segment is attributed to the growing volume of production of pharmaceuticals and advancements in primary packaging and drug delivery devices. Additionally, with the rising number of drug approvals, the demand for primary packaging is increasing which is supporting the demand for pharmaceutical packaging market. For instance, in 2023, the U.S. FDA approved 55 drugs in comparison to 37 drugs in 2022.
Based on Dosage Form, the Oral Dosage Form Segment Dominated the Market
Based on dosage form, the pharmaceutical packaging market is segmented into oral dosage form, parenteral dosage form, and other dosage forms. In 2024, the oral dosage form segment is expected to account for the largest share of the pharmaceutical packaging market. The large market share of this segment can be attributed to patients' inclination towards oral medications, the reliable and efficient delivery of drugs via oral administration, and ongoing innovations in oral drug packaging solutions. Recent advancements in oral drug formulation packaging include the introduction of child-resistant and senior-friendly packaging, sustainable packaging solutions, and designs tailored to meet patient needs. For instance, in February 2023, Berry Global Group, Inc. (U.S.) launched a new PET bottle combination designed for pharmaceutical syrups. This packaging solution aims to assist customers in meeting the growing demand for child-resistant and tamper-evident packaging.
Based on End User, the Pharmaceutical Companies Segment is Projected to Register the Highest CAGR During the Forecast Period
Based on end user, the pharmaceutical packaging market is segmented into pharmaceutical companies, contract companies, and pharmacies. The contract companies’ segment is projected to register the highest CAGR during the forecast period. Pharmaceutical companies are increasingly outsourcing their drug packaging to contract companies due to the increasing cost of product development, rising pricing constraints, and the lack of extensive in-house R&D infrastructure among small and medium-sized companies. The increasing number of clinical trials and rapid growth in the healthcare and life sciences industries are driving packaging outsourcing to ensure quick and cost-effective pharmaceutical packaging. According to a report published by the Association for Packaging and Processing Technologies (U.S.) in 2022, 60% of pharmaceutical manufacturers outsource at least a portion of their operations to a third-party contractor.
North America: Largest Regional Market
In 2024, North America is expected to account for the largest share of the pharmaceutical packaging market. North America's significant market share can be attributed to several factors, including increased manufacturing capacities of pharmaceutical and biopharmaceutical companies in the region, the adoption of advanced digital tools approved by regulatory authorities to enhance the packaging process, and well-organized regulations governing packaging and labeling in the pharmaceutical industry. Additionally, the presence of major pharmaceutical packaging companies, including Catalent, Inc. (U.S.), Corning Inc. (U.S.), Berry Global Group, Inc. (U.S.), Drug Plastics Group (U.S.), and AptarGroup, Inc. (U.S.) in the U.S. further contributes to the region's large market share.
Pharmaceutical Packaging Market: Competitive Analysis
The report offers a competitive landscape based on an extensive assessment of the product offerings and geographic presence of leading market players and the key growth strategies adopted by them over the past few years 2021–2024. The key players operating in the global pharmaceutical packaging market are Amcor plc (Switzerland), AptarGroup, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Gerresheimer AG (Germany), Schott Pharma AG & Co. KGaA (Germany), Berry Global Group, Inc. (U.S.), Drug Plastics Group (U.S.), Catalent, Inc. (U.S.), SGD Pharma (France), Corning Inc. (U.S.), WestRock Company (U.S.), and West Pharmaceutical Services, Inc. (U.S.).
Pharmaceutical Packaging Market Report Summary:
|
Particulars |
Details |
|
Number of Pages |
348 |
|
Format |
|
|
Forecast Period |
2024-2031 |
|
Base Year |
2023 |
|
CAGR |
7.6% |
|
Estimated Market Size (Value) |
$176.54 billion by 2031 |
|
Segments Covered |
By Material
By Packaging Type
By Dosage Form
By End User
|
|
Countries Covered |
North America (U.S., Canada), Europe (Switzerland, Italy, Germany, France, U.K., Ireland, Belgium, Spain, Denmark, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Rest of Latin America), and Middle East & Africa |
|
Key Companies |
Amcor plc (Switzerland), AptarGroup, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Gerresheimer AG (Germany), Schott Pharma AG & Co. KGaA (Germany), Berry Global Group, Inc. (U.S.), Drug Plastics Group (U.S.), Catalent, Inc. (U.S.), SGD Pharma (France), Corning Inc. (U.S.), WestRock Company (U.S.), and West Pharmaceutical Services, Inc. (U.S.). |
Key questions answered in the report:
The global pharmaceutical packaging market covers the study of various materials used for pharmaceutical packaging manufacturing, along with the packaging type, dosage form, and end user. This report also involves the analysis of various segments of pharmaceutical packaging at the regional and country levels.
The global pharmaceutical packaging market is projected to reach $176.54 billion by 2031 at a CAGR of 7.6% from 2024 to 2031.
Among all the materials studied in this report, in 2024, the polymer segment is expected to account for the largest share of the pharmaceutical packaging market. The segment’s large share is attributed to the wide availability of polymers, the cost-effectiveness of polymers compared to other packaging materials, such as glass and metal, and the effectiveness of polymers in protecting pharmaceutical preparations against external damage and contamination.
Among all the packaging types studied in this report, in 2024, the primary packaging segment is expected to account for the largest share of the pharmaceutical packaging market. This large share is attributed to the high volume of pharmaceutical production and advancements in primary packaging and drug delivery devices. Additionally, with the rising number of drug approvals, the demand for primary packaging is increasing.
The growth of the pharmaceutical packaging market is driven by growth in the pharmaceutical sector, the rising demand for drug delivery devices, growing healthcare expenditures, the increasing focus on biosimilars, the growing trend of contract manufacturing & packaging in the pharmaceutical sector, and growth in the aging population & the consequent rise in chronic disease prevalence.
Furthermore, the rising adoption of personalized medicines & self-medication, improving healthcare provisions in emerging economies, the growth in pharmaceutical R&D spending, and the increasing focus on vaccine development & vaccination coverage are expected to generate growth opportunities for the players operating in this market.
The key players operating in the global pharmaceutical packaging market are Amcor plc (Switzerland), AptarGroup, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Gerresheimer AG (Germany), Schott Pharma AG & Co. KGaA (Germany), Berry Global Group, Inc. (U.S.), Drug Plastics Group (U.S.), Catalent, Inc. (U.S.), SGD Pharma (France), Corning Inc. (U.S.), WestRock Company (U.S.), and West Pharmaceutical Services, Inc. (U.S.).
The countries in Asia-Pacific are projected to offer significant growth opportunities for the vendors in this market. Countries such as India and South Korea are expected to grow with considerable CAGR in the pharmaceutical packaging market. The growth of the pharmaceutical packaging market in India is driven by the growth in domestic consumption of pharmaceuticals and the increasing manufacturing of several pharmaceutical products in the country. Furthermore, government initiatives supporting the growth of pharmaceutical manufacturing in the country are expected to drive the market's growth. Additionally, companies operating in South Korea are actively focusing on increasing their presence in the country due to the potential market opportunities and supportive government initiatives. For instance, in August 2021, ExoCoBio, Inc. (South Korea) started building its drug manufacturing and research & development facilities in South Korea.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecasting
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Impact Analysis of Market Dynamics
4.2.1.1. Exponential Growth Driving the Demand for Packaging in the Pharmaceutical Sector
4.2.1.2. Increasing Instances of Counterfeit Packaging Restraining Market Growth
4.2.1.3. Rising Adoption of Personalized Medicines & Self-Medication Generating Growth Opportunities for Market Players
4.2.1.4. Changing Regulatory Regimes Expected to Remain a Major Challenge for Market Stakeholders
4.2.2. Factor Analysis
4.3. Key Market Trends
4.3.1. A Shift Toward Sustainable Packaging
4.3.2. Smart Packaging
4.3.3. Child-resistant Packaging
4.4. Raw Material Pricing Analysis
4.4.1. Polyethylene (PE)
4.4.2. Polypropylene (PP)
4.4.3. Polyethylene Terephthalate (PET)
4.4.4. Polyvinyl Chloride (PVC)
4.4.5. Metal (Aluminum)
4.5. Sustainability Policies
4.5.1. North America: Implementing EPR (Extended Producer Responsibility)
4.5.2. Europe: Focus On Implementing a Circular Economy
4.5.3. Asia-Pacific: Implementing Recycling Programs
4.6. Regulatory Analysis
4.6.1. North America
4.6.1.1. U.S.
4.6.1.2. Canada
4.6.2. Europe
4.6.3. Asia-Pacific
4.6.3.1. China
4.6.3.2. India
4.6.3.3. Japan
4.6.4. Latin America
4.6.4.1. Brazil
4.6.5. Middle East
4.6.5.1. Saudi Arabia
4.7. Porter’s Five Forces Analysis
4.7.1. Bargaining Power of Buyers
4.7.2. Bargaining Power of Suppliers
4.7.3. Threat of Substitutes
4.7.4. Threat of New Entrants
4.7.5. Degree of Competition
4.8. Value Chain Analysis
5. Pharmaceutical Packaging Market Assessment—by Material
5.1. Overview
5.2. Polymer
5.2.1. Polyvinyl Chloride (PVC)
5.2.2. Polyethylene Terephthalate (PET)
5.2.3. Polypropylene (PP)
5.2.4. Polyethylene (PE)
5.2.5. Other Polymers
5.3. Glass
5.4. Paper & Paperboard
5.5. Metal
5.6. Other Packaging Materials
6. Pharmaceutical Packaging Market Assessment—by Packaging Type
6.1. Overview
6.2. Primary Packaging
6.2.1. Blister Packaging
6.2.2. Bottles
6.2.3. Vials & Ampoules
6.2.4. Caps & Closures
6.2.5. Pre-fillable Inhalers
6.2.6. Pre-fillable Syringes & Cartridges
6.2.7. Pouches & Sachets
6.2.8. Other Primary Packaging
6.3. Secondary Packaging
6.4. Tertiary Packaging
7. Pharmaceutical Packaging Market Assessment—by Dosage Form
7.1. Overview
7.2. Oral Dosage Form
7.2.1. Oral Solid Dosage
7.2.2. Oral Liquid Dosage
7.3. Parenteral Dosage Form
7.4. Other Dosage Forms
8. Pharmaceutical Packaging Market Assessment—by End User
8.1. Overview
8.2. Pharmaceutical Companies
8.3. Contract Companies
8.4. Pharmacies
9. Pharmaceutical Packaging Market Assessment—by Geography
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Switzerland
9.3.2. Italy
9.3.3. Germany
9.3.4. France
9.3.5. U.K.
9.3.6. Ireland
9.3.7. Belgium
9.3.8. Spain
9.3.9. Denmark
9.3.10. Rest of Europe
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. South Korea
9.4.5. Australia
9.4.6. Rest of Asia-Pacific
9.5. Latin America
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
9.6. Middle East & Africa
10. Competition Analysis
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Competitive Dashboard
10.4.1. Industry Leaders
10.4.2. Market Differentiators
10.4.3. Vanguards
10.4.4. Emerging Companies
11. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)
11.1. Amcor plc
11.2. AptarGroup, Inc.
11.3. Becton, Dickinson and Company
11.4. Gerresheimer AG
11.5. Corning Inc.
11.6. Schott Pharma AG & Co. KGaA
11.7. Berry Global Group, Inc.
11.8. Drug Plastics Group
11.9. Catalent, Inc.
11.10. SGD Pharma
11.11. WestRock Company
11.12. West Pharmaceutical Services, Inc.
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)
12. Appendix
12.1. Available Customization
12.2. Related Reports
List of Tables
Table 1 Smart Packaging Innovations
Table 2 Child-resistant Packaging
Table 3 Global Pharmaceutical Packaging Market, by Material, 2022-2031 (USD Million)
Table 4 Global Polymer-based Pharmaceutical Packaging Market, by Type, 2022-2031 (USD Million)
Table 5 Global Polymer-based Pharmaceutical Packaging Market, by Country/Region, 2022-2031 (USD Million)
Table 6 Global PVC-based Pharmaceutical Packaging Market, by Country/Region, 2022-2031 (USD Million)
Table 7 Properties of PET Material
Table 8 Global PET-based Pharmaceutical Packaging Market, by Country/Region, 2022-2031 (USD Million)
Table 9 Properties of Polypropylene
Table 10 Global Polypropylene-based Pharmaceutical Packaging Market, by Country/Region, 2022-2031 (USD Million)
Table 11 Properties of PE Material
Table 12 Global Polyethylene-based Pharmaceutical Packaging Market, by Country/Region, 2022-2031 (USD Million)
Table 13 Global Pharmaceutical Packaging Market for Other Polymers, by Country/Region, 2022-2031 (USD Million)
Table 14 Types of Glass Used in Pharmaceutical Packaging
Table 15 Global Glass-based Pharmaceutical Packaging Market, by Country/Region, 2022-2031 (USD Million)
Table 16 Global Paper & Paperboard-based Pharmaceutical Packaging Market, by Country/Region, 2022-2031 (USD Million)
Table 17 Use of Metals in Pharmaceutical Packaging
Table 18 Global Metal-based Pharmaceutical Packaging Market, by Country/Region, 2022-2031 (USD Million)
Table 19 Other Pharmaceutical Packaging Materials Market, by Country/Region, 2022-2031 (USD Million)
Table 20 Global Pharmaceutical Packaging Market, by Packaging Type, 2022-2031 (USD Million)
Table 21 Global Primary Pharmaceutical Packaging Market, by Type, 2022-2031 (USD Million)
Table 22 Global Primary Pharmaceutical Packaging Market, by Country/Region, 2022-2031 (USD Million)
Table 23 Benefits Offered by Blister Packaging
Table 24 Global Primary Pharmaceutical Packaging Market for Blister Packaging, by Country/Region, 2022-2031 (USD Million)
Table 25 Global Primary Pharmaceutical Packaging Market for Bottles, by Country/Region, 2022-2031 (USD Million)
Table 26 Benefits of Vial Packaging
Table 27 Global Primary Pharmaceutical Packaging Market for Vials & Ampoules, by Country/Region, 2022-2031 (USD Million)
Table 28 Global Primary Pharmaceutical Packaging Market for Caps & Closures, by Country/Region, 2022-2031 (USD Million)
Table 29 Global Primary Pharmaceutical Packaging Market for Pre-fillable Inhalers, by Country/Region, 2022-2031 (USD Million)
Table 30 Global Primary Pharmaceutical Packaging Market for Pre-fillable Syringes & Cartridges, by Country/Region, 2022-2031 (USD Million)
Table 31 Global Primary Pharmaceutical Packaging Market for Pouches & Sachets, by Country/Region, 2022-2031 (USD Million)
Table 32 Global Primary Pharmaceutical Packaging Market for Other Primary Packaging, by Country/Region, 2022-2031 (USD Million)
Table 33 Global Secondary Pharmaceutical Packaging Market, by Country/Region, 2022-2031 (USD Million)
Table 34 Global Tertiary Pharmaceutical Packaging Market, by Country/Region, 2022-2031 (USD Million)
Table 35 Global Pharmaceutical Packaging Market, by Dosage Form, 2022-2031 (USD Million)
Table 36 Global Pharmaceutical Packaging Market for Oral Dosage Form, by Type, 2022-2031 (USD Million)
Table 37 Global Pharmaceutical Packaging Market for Oral Dosage Form, by Country/Region, 2022-2031 (USD Million)
Table 38 Global Pharmaceutical Packaging Market for Oral Solid Dosage, by Country/Region, 2022-2031 (USD Million)
Table 39 Global Pharmaceutical Packaging Market for Oral Liquid Dosage, by Country/Region, 2022-2031 (USD Million)
Table 40 Parenteral Dosage Form Packaging Types
Table 41 Global Pharmaceutical Packaging Market for Parenteral Dosage Form, by Country/Region, 2022-2031 (USD Million)
Table 42 Global Pharmaceutical Packaging Market for Other Dosage Forms, by Country/Region, 2022-2031 (USD Million)
Table 43 Global Pharmaceutical Packaging Market, by End User, 2022-2031 (USD Million)
Table 44 Global Pharmaceutical Packaging Market for Pharmaceutical Companies, by Country/Region, 2022-2031 (USD Million)
Table 45 Global Pharmaceutical Packaging Market for Contract Companies, by Country/Region, 2022-2031 (USD Million)
Table 46 Global Pharmaceutical Packaging Market for Pharmacies, by Country/Region, 2022-2031 (USD Million)
Table 47 Global Pharmaceutical Packaging Market, by Country/Region, 2022–2031 (USD Million)
Table 48 North America: Pharmaceutical Packaging Market, by Country, 2022–2031 (USD Million)
Table 49 North America: Pharmaceutical Packaging Market, by Material, 2022–2031 (USD Million)
Table 50 North America: Polymer-based Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 51 North America: Pharmaceutical Packaging Market, by Packaging Type, 2022–2031 (USD Million)
Table 52 North America: Primary Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 53 North America: Pharmaceutical Packaging Market, by Dosage Form, 2022–2031 (USD Million)
Table 54 North America: Pharmaceutical Packaging Market for Oral Dosage Form, by Type, 2022–2031 (USD Million)
Table 55 North America: Pharmaceutical Packaging Market, by End User, 2022–2031 (USD Million)
Table 56 U.S.: Pharmaceutical Packaging Market, by Material, 2022–2031 (USD Million)
Table 57 U.S.: Polymer-based Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 58 U.S.: Pharmaceutical Packaging Market, by Packaging Type, 2022–2031 (USD Million)
Table 59 U.S.: Primary Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 60 U.S.: Pharmaceutical Packaging Market, by Dosage Form, 2022–2031 (USD Million)
Table 61 U.S.: Pharmaceutical Packaging Market for Oral Dosage Form, by Type, 2022–2031 (USD Million)
Table 62 U.S.: Pharmaceutical Packaging Market, by End User, 2022–2031 (USD Million)
Table 63 Canada: Pharmaceutical Packaging Market, by Material, 2022–2031 (USD Million)
Table 64 Canada: Polymer-based Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 65 Canada: Pharmaceutical Packaging Market, by Packaging Type, 2022–2031 (USD Million)
Table 66 Canada: Primary Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 67 Canada: Pharmaceutical Packaging Market, by Dosage Form, 2022–2031 (USD Million)
Table 68 Canada: Pharmaceutical Packaging Market for Oral Dosage Form, by Type, 2022–2031 (USD Million)
Table 69 Canada: Pharmaceutical Packaging Market, by End User, 2022–2031 (USD Million)
Table 70 Europe: Pharmaceutical Packaging Market, by Country/Region, 2022–2031 (USD Million)
Table 71 Europe: Pharmaceutical Packaging Market, by Material, 2022–2031 (USD Million)
Table 72 Europe: Polymer-based Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 73 Europe: Pharmaceutical Packaging Market, by Packaging Type, 2022–2031 (USD Million)
Table 74 Europe: Primary Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 75 Europe: Pharmaceutical Packaging Market, by Dosage Form, 2022–2031 (USD Million)
Table 76 Europe: Pharmaceutical Packaging Market for Oral Dosage Form, by Type, 2022–2031 (USD Million)
Table 77 Europe: Pharmaceutical Packaging Market, by End User, 2022–2031 (USD Million)
Table 78 Switzerland: Pharmaceutical Packaging Market, by Material, 2022–2031 (USD Million)
Table 79 Switzerland: Polymer-based Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 80 Switzerland: Pharmaceutical Packaging Market, by Packaging Type, 2022–2031 (USD Million)
Table 81 Switzerland: Primary Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 82 Switzerland: Pharmaceutical Packaging Market, by Dosage Form, 2022–2031 (USD Million)
Table 83 Switzerland: Pharmaceutical Packaging Market for Oral Dosage Form, by Type, 2022–2031 (USD Million)
Table 84 Switzerland: Pharmaceutical Packaging Market, by End User, 2022–2031 (USD Million)
Table 85 Italy: Pharmaceutical Packaging Market, by Material, 2022–2031 (USD Million)
Table 86 Italy: Polymer-based Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 87 Italy: Pharmaceutical Packaging Market, by Packaging Type, 2022–2031 (USD Million)
Table 88 Italy: Primary Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 89 Italy: Pharmaceutical Packaging Market, by Dosage Form, 2022–2031 (USD Million)
Table 90 Italy: Pharmaceutical Packaging Market, by Oral Dosage Form, 2022–2031 (USD Million)
Table 91 Italy: Pharmaceutical Packaging Market, by End User, 2022–2031 (USD Million)
Table 92 Germany: Pharmaceutical Packaging Market, by Material, 2022–2031 (USD Million)
Table 93 Germany: Polymer-based Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 94 Germany: Pharmaceutical Packaging Market, by Packaging Type, 2022–2031 (USD Million)
Table 95 Germany: Primary Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 96 Germany: Pharmaceutical Packaging Market, by Dosage Form, 2022–2031 (USD Million)
Table 97 Germany: Pharmaceutical Packaging Market for Oral Dosage Form, by Type, 2022–2031 (USD Million)
Table 98 Germany: Pharmaceutical Packaging Market, by End User, 2022–2031 (USD Million)
Table 99 France Pharmaceutical R&D Expenditure and Market Value, 2020 Vs. 2021 (USD Million)
Table 100 France: Pharmaceutical Packaging Market, by Material, 2022–2031 (USD Million)
Table 101 France: Polymer-based Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 102 France: Pharmaceutical Packaging Market, by Packaging Type, 2022–2031 (USD Million)
Table 103 France: Primary Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 104 France: Pharmaceutical Packaging Market, by Dosage Form, 2022–2031 (USD Million)
Table 105 France: Pharmaceutical Packaging Market for Oral Dosage Form, by Type, 2022–2031 (USD Million)
Table 106 France: Pharmaceutical Packaging Market, by End User, 2022–2031 (USD Million)
Table 107 U.K.: Pharmaceutical Packaging Market, by Material, 2022–2031 (USD Million)
Table 108 U.K.: Polymer-based Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 109 U.K.: Pharmaceutical Packaging Market, by Packaging Type, 2022–2031 (USD Million)
Table 110 U.K.: Primary Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 111 U.K.: Pharmaceutical Packaging Market, by Dosage Form, 2022–2031 (USD Million)
Table 112 U.K.: Pharmaceutical Packaging Market, by Oral Dosage Form, 2022–2031 (USD Million)
Table 113 U.K.: Pharmaceutical Packaging Market, by End User, 2022–2031 (USD Million)
Table 114 Ireland: Pharmaceutical Packaging Market, by Material, 2022–2031 (USD Million)
Table 115 Ireland: Polymer-based Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 116 Ireland: Pharmaceutical Packaging Market, by Packaging Type, 2022–2031 (USD Million)
Table 117 Ireland: Primary Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 118 Ireland: Pharmaceutical Packaging Market, by Dosage Form, 2022–2031 (USD Million)
Table 119 Ireland: Pharmaceutical Packaging Market for Oral Dosage Form, by Type, 2022–2031 (USD Million)
Table 120 Ireland: Pharmaceutical Packaging Market, by End User, 2022–2031 (USD Million)
Table 121 Belgium: Pharmaceutical Packaging Market, by Material, 2022–2031 (USD Million)
Table 122 Belgium: Polymer-based Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 123 Belgium: Pharmaceutical Packaging Market, by Packaging Type, 2022–2031 (USD Million)
Table 124 Belgium: Primary Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 125 Belgium: Pharmaceutical Packaging Market, by Dosage Form, 2022–2031 (USD Million)
Table 126 Belgium: Pharmaceutical Packaging Market for Oral Dosage Form, by Type, 2022–2031 (USD Million)
Table 127 Belgium: Pharmaceutical Packaging Market, by End User, 2022–2031 (USD Million)
Table 128 Spain: Pharmaceutical Packaging Market, by Material, 2022–2031 (USD Million)
Table 129 Spain: Polymer-based Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 130 Spain: Pharmaceutical Packaging Market, by Packaging Type, 2022–2031 (USD Million)
Table 131 Spain: Primary Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 132 Spain: Pharmaceutical Packaging Market, by Dosage Form, 2022–2031 (USD Million)
Table 133 Spain: Pharmaceutical Packaging Market for Oral Dosage Form, by Type, 2022–2031 (USD Million)
Table 134 Spain: Pharmaceutical Packaging Market, by End User, 2022–2031 (USD Million)
Table 135 Denmark: Pharmaceutical Packaging Market, by Material, 2022–2031 (USD Million)
Table 136 Denmark: Polymer-based Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 137 Denmark: Pharmaceutical Packaging Market, by Packaging Type, 2022–2031 (USD Million)
Table 138 Denmark: Primary Pharmaceutical Packaging Market, by Type, 2022–2031(USD Million)
Table 139 Denmark: Pharmaceutical Packaging Market, by Dosage Form, 2022–2031 (USD Million)
Table 140 Denmark: Pharmaceutical Packaging Market for Oral Dosage Form, by Type, 2022–2031 (USD Million)
Table 141 Denmark: Pharmaceutical Packaging Market, by End User, 2022–2031 (USD Million)
Table 142 Rest of Europe: Pharmaceutical Packaging Market, by Material, 2022–2031 (USD Million)
Table 143 Rest of Europe: Polymer-based Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 144 Rest of Europe: Pharmaceutical Packaging Market, by Packaging Type, 2022–2031 (USD Million)
Table 145 Rest of Europe: Primary Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 146 Rest of Europe: Pharmaceutical Packaging Market, by Dosage Form, 2022–2031 (USD Million)
Table 147 Rest of Europe: Pharmaceutical Packaging Market for Oral Dosage Form, by Type, 2022–2031 (USD Million)
Table 148 Rest of Europe: Pharmaceutical Packaging Market, by End User, 2022–2031 (USD Million)
Table 149 Asia-Pacific: Pharmaceutical Packaging Market, by Country/Region, 2022–2031 (USD Million)
Table 150 Asia-Pacific: Pharmaceutical Packaging Market, by Material, 2022–2031 (USD Million)
Table 151 Asia-Pacific: Polymer-based Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 152 Asia-Pacific: Pharmaceutical Packaging Market, by Packaging Type, 2022–2031 (USD Million)
Table 153 Asia-Pacific: Primary Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 154 Asia-Pacific: Pharmaceutical Packaging Market, by Dosage Form, 2022–2031 (USD Million)
Table 155 Asia-Pacific: Pharmaceutical Packaging Market for Oral Dosage Form, by Type, 2022–2031 (USD Million)
Table 156 Asia-Pacific: Pharmaceutical Packaging Market, by End User, 2022–2031 (USD Million)
Table 157 China: Pharmaceutical Packaging Market, by Material, 2022–2031 (USD Million)
Table 158 China: Polymer-based Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 159 China: Pharmaceutical Packaging Market, by Packaging Type, 2022–2031 (USD Million)
Table 160 China: Primary Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 161 China: Pharmaceutical Packaging Market, by Dosage Form, 2022–2031 (USD Million)
Table 162 China: Pharmaceutical Packaging Market for Oral Dosage Form, by Type, 2022–2031 (USD Million)
Table 163 China: Pharmaceutical Packaging Market, by End User, 2022–2031 (USD Million)
Table 164 Japan: Pharmaceutical Packaging Market, by Material, 2022–2031 (USD Million)
Table 165 Japan: Polymer-based Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 166 Japan: Pharmaceutical Packaging Market, by Packaging Type, 2022–2031 (USD Million)
Table 167 Japan: Primary Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 168 Japan: Pharmaceutical Packaging Market, by Dosage Form, 2022–2031 (USD Million)
Table 169 Japan: Pharmaceutical Packaging Market, by Oral Dosage Form, 2022–2031 (USD Million)
Table 170 Japan: Pharmaceutical Packaging Market, by End User, 2022–2031 (USD Million)
Table 171 India: Pharmaceutical Packaging Market, by Material, 2022–2031 (USD Million)
Table 172 India: Polymer-based Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 173 India: Pharmaceutical Packaging Market, by Packaging Type, 2022–2031 (USD Million)
Table 174 India: Primary Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 175 India: Pharmaceutical Packaging Market, by Dosage Form, 2022–2031 (USD Million)
Table 176 India: Pharmaceutical Packaging Market for Oral Dosage Form, by Type, 2022–2031 (USD Million)
Table 177 India: Pharmaceutical Packaging Market, by End User, 2022–2031 (USD Million)
Table 178 South Korea: Pharmaceutical Packaging Market, by Material, 2022–2031 (USD Million)
Table 179 South Korea: Polymer-based Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 180 South Korea: Pharmaceutical Packaging Market, by Packaging Type, 2022–2031 (USD Million)
Table 181 South Korea: Primary Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 182 South Korea: Pharmaceutical Packaging Market, by Dosage Form, 2022–2031 (USD Million)
Table 183 South Korea: Pharmaceutical Packaging Market for Oral Dosage Form, by Type, 2022–2031 (USD Million)
Table 184 South Korea: Pharmaceutical Packaging Market, by End User, 2022–2031 (USD Million)
Table 185 Australia: Pharmaceutical Packaging Market, by Material, 2022–2031 (USD Million)
Table 186 Australia: Polymer-based Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 187 Australia: Pharmaceutical Packaging Market, by Packaging Type, 2022–2031 (USD Million)
Table 188 Australia: Primary Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 189 Australia: Pharmaceutical Packaging Market, by Dosage Form, 2022–2031 (USD Million)
Table 190 Australia: Pharmaceutical Packaging Market for Oral Dosage Form, by Type, 2022–2031 (USD Million)
Table 191 Australia: Pharmaceutical Packaging Market, by End User, 2022–2031 (USD Million)
Table 192 Rest of Asia-Pacific: Pharmaceutical Packaging Market, by Material, 2022–2031 (USD Million)
Table 193 Rest of Asia-Pacific: Polymer-based Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 194 Rest of Asia-Pacific: Pharmaceutical Packaging Market, by Packaging Type, 2022–2031 (USD Million)
Table 195 Rest of Asia-Pacific: Primary Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 196 Rest of Asia-Pacific: Pharmaceutical Packaging Market, by Dosage Form, 2022–2031 (USD Million)
Table 197 Rest of Asia-Pacific: Pharmaceutical Packaging Market for Oral Dosage Form, by Type, 2022–2031 (USD Million)
Table 198 Rest of Asia-Pacific: Pharmaceutical Packaging Market, by End User, 2022–2031 (USD Million)
Table 199 Latin America: Pharmaceutical Packaging Market, by Country/Region, 2022–2031 (USD Million)
Table 200 Latin America: Pharmaceutical Packaging Market, by Material, 2022–2031 (USD Million)
Table 201 Latin America: Polymer-based Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 202 Latin America: Pharmaceutical Packaging Market, by Packaging Type, 2022–2031 (USD Million)
Table 203 Latin America: Primary Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 204 Latin America: Pharmaceutical Packaging Market, by Dosage Form, 2022–2031 (USD Million)
Table 205 Latin America: Pharmaceutical Packaging Market for Oral Dosage Form, by Type, 2022–2031 (USD Million)
Table 206 Latin America: Pharmaceutical Packaging Market, by End User, 2022–2031 (USD Million)
Table 207 Brazil: Pharmaceutical Packaging Market, by Material, 2022–2031 (USD Million)
Table 208 Brazil: Polymer-based Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 209 Brazil: Pharmaceutical Packaging Market, by Packaging Type, 2022–2031 (USD Million)
Table 210 Brazil: Primary Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 211 Brazil: Pharmaceutical Packaging Market, by Dosage Form, 2022–2031 (USD Million)
Table 212 Brazil: Pharmaceutical Packaging Market for Oral Dosage Form, by Type, 2022–2031 (USD Million)
Table 213 Brazil: Pharmaceutical Packaging Market, by End User, 2022–2031 (USD Million)
Table 214 Mexico: Pharmaceutical Packaging Market, by Material, 2022–2031 (USD Million)
Table 215 Mexico: Polymer-based Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 216 Mexico: Pharmaceutical Packaging Market, by Packaging Type, 2022–2031 (USD Million)
Table 217 Mexico: Primary Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 218 Mexico: Pharmaceutical Packaging Market, by Dosage Form, 2022–2031 (USD Million)
Table 219 Mexico: Pharmaceutical Packaging Market for Oral Dosage Form, by Type,2022–2031 (USD Million)
Table 220 Mexico: Pharmaceutical Packaging Market, by End User, 2022–2031 (USD Million)
Table 221 Rest of Latin America: Pharmaceutical Packaging Market, by Material, 2022–2031 (USD Million)
Table 222 Rest of Latin America: Polymer-based Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 223 Rest of Latin America: Pharmaceutical Packaging Market, by Packaging Type, 2022–2031 (USD Million)
Table 224 Rest of Latin America: Primary Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 225 Rest of Latin America: Pharmaceutical Packaging Market, by Dosage Form, 2022–2031 (USD Million)
Table 226 Rest of Latin America: Pharmaceutical Packaging Market for Oral Dosage Form, by Type, 2022–2031 (USD Million)
Table 227 Rest of Latin America: Pharmaceutical Packaging Market, by End User, 2022–2031 (USD Million)
Table 228 Middle East & Africa: Pharmaceutical Packaging Market, by Material, 2022–2031 (USD Million)
Table 229 Middle East & Africa: Polymer-based Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 230 Middle East & Africa: Pharmaceutical Packaging Market, by Packaging Type, 2022–2031 (USD Million)
Table 231 Middle East & Africa: Primary Pharmaceutical Packaging Market, by Type, 2022–2031 (USD Million)
Table 232 Middle East & Africa: Pharmaceutical Packaging Market, by Dosage Form, 2022–2031 (USD Million)
Table 233 Middle East & Africa: Pharmaceutical Packaging Market for Oral Dosage Form, by Type, 2022–2031 (USD Million)
Table 234 Middle East & Africa: Pharmaceutical Packaging Market, by End User, 2022–2031 (USD Million)
Table 235 Recent Developments, by Company, 2021–2024
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for This Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Pharmaceutical Packaging Market, by Material, 2024 VS. 2031 (USD Million)
Figure 8 Global Pharmaceutical Packaging Market, by Packaging Type, 2024 Vs. 2031 (USD Million)
Figure 9 Global Pharmaceutical Packaging Market, by Dosage Form, 2024 Vs. 2031 (USD Million)
Figure 10 Global Pharmaceutical Packaging Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 11 Pharmaceutical Packaging Market, by Geography
Figure 12 Impact Analysis of Market Dynamics
Figure 13 Global Pharmaceutical R&D Expenditure, 2012–2026 (USD Billion)
Figure 14 U.S.: Percentage of Personalized Medicine Approvals Among Total FDA Approvals, 2015-2022 (%)
Figure 15 Global Number of Pharmaceutical Crimes, 2018-2022
Figure 16 Number of New Chemical and Biological Entities, 2013-2022
Figure 17 Polyethylene Pricing Trend (USD/T)
Figure 18 Polypropylene Pricing Trend (USD/T)
Figure 19 PET Pricing Trend (USD/T)
Figure 20 PVC Pricing Trend (USD/T)
Figure 21 Aluminum Price Trend (USD/T)
Figure 22 U.S. FDA Pharmaceutical Packaging Acts
Figure 23 Porter’s Five Forces Analysis
Figure 24 Value Chain Analysis
Figure 25 Global Pharmaceutical Packaging, by Material, 2024 Vs. 2031 (USD Million)
Figure 26 Europe: Paper & Paperboard Production and Consumption for Packaging Applications (Thousand Tonnes)
Figure 27 Global Pharmaceutical Packaging Market, by Packaging Type, 2024 VS. 2031 (USD Million)
Figure 28 Global Pharmaceutical Packaging, by Dosage Form, 2024 VS. 2031 (USD Million)
Figure 29 Global Pharmaceutical Packaging Market, by End User, 2024 VS. 2031 (USD Million)
Figure 30 Global Pharmaceutical Packaging Market Assessment, by Country/Region, 2024 VS. 2031 (USD Million)
Figure 31 North America: Pharmaceutical Packaging Market Snapshot
Figure 32 Europe: Pharmaceutical Packaging Market Snapshot
Figure 33 Switzerland: Pharmaceutical Production, 2018-2021 (USD Million)
Figure 34 Italy: Number of Biotechnology Firms, 2018-2022
Figure 35 France: Population Aged 65 Years and Above, 2015 Vs. 2021
Figure 36 Belgium Pharmaceutical Production, 2018-2021 (USD Million)
Figure 37 Asia-Pacific: Pharmaceutical Packaging Market Snapshot
Figure 38 India's Drug and Pharmaceutical Export Trend (USD Billion), 2017–2022
Figure 39 Latin America: Pharmaceutical Packaging Market Snapshot
Figure 40 Key Growth Strategies Adopted by Leading Players, 2021–2024
Figure 41 Pharmaceutical Packaging Market: Competitive Benchmarking, by Packaging Type
Figure 42 Pharmaceutical Packaging Market: Competitive Benchmarking, by Primary Packaging Type
Figure 43 Pharmaceutical Packaging Market: Competitive Benchmarking, by Geography
Figure 44 Competitive Dashboard: Pharmaceutical Packaging Market
Figure 45 Amcor Plc: Financial Overview (2023)
Figure 46 AptarGroup, Inc.: Financial Overview (2023)
Figure 47 Becton, Dickinson and Company: Financial Overview (2023)
Figure 48 Gerresheimer AG: Financial Overview (2023)
Figure 49 Corning Inc.: Financial Snapshot (2023)
Figure 50 Schott Pharma AG & Co. KGaA: Financial Overview (2023)
Figure 51 Berry Global Group, Inc.: Financial Overview (2023)
Figure 52 Catalent Inc.: Financial Snapshot (2023)
Figure 53 WestRock Company: Financial Snapshot (2023)
Figure 54 West Pharmaceuticals Services Inc.: Financial Snapshot (2023)
Author Name:
Proudly Partnering With Enterprises Around the Globe
Quick Contact
